Role of glial cells in innate immunity and their role in CNS demyelination

[1]  J. Turner,et al.  Neurodegeneration by activated microglia across a nanofiltration membrane , 2012, Journal of biochemical and molecular toxicology.

[2]  K. Kyvik,et al.  Neuromyelitis optica (NMO) – an autoimmune disease of the central nervous system (CNS) , 2011, Acta neurologica Scandinavica.

[3]  M. Lamkanfi.  Emerging inflammasome effector mechanisms , 2011, Nature Reviews Immunology.

[4]  L. Galluzzi,et al.  Mitochondrial control of the NLRP3 inflammasome , 2011, Nature Immunology.

[5]  H. D. de Vries,et al.  Radical changes in multiple sclerosis pathogenesis. , 2011, Biochimica et biophysica acta.

[6]  A. Mildner,et al.  Microglia in the CNS: Immigrants from another world , 2011, Glia.

[7]  C. Wegner,et al.  Inflammation, demyelination, and degeneration - recent insights from MS pathology. , 2011, Biochimica et biophysica acta.

[8]  S. Wai,et al.  NOD-Like Receptor Activation by Outer Membrane Vesicles from Vibrio cholerae Non-O1 Non-O139 Strains Is Modulated by the Quorum-Sensing Regulator HapR , 2011, Infection and Immunity.

[9]  S. Yao,et al.  In vitro and in vivo induction and activation of nNOS by LPS in oligodendrocytes , 2010, Journal of Neuroimmunology.

[10]  Songbin Fu,et al.  A Novel Toll-like Receptor That Recognizes Vesicular Stomatitis Virus* , 2010, The Journal of Biological Chemistry.

[11]  Carolyn R. Sturge,et al.  UNC93B1 Is Essential for TLR11 Activation and IL-12-dependent Host Resistance to Toxoplasma gondii* , 2010, The Journal of Biological Chemistry.

[12]  R. Ransohoff,et al.  The myeloid cells of the central nervous system parenchyma , 2010, Nature.

[13]  M. Graeber.  Changing Face of Microglia , 2010, Science.

[14]  J. Parratt,et al.  Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes , 2010, Multiple sclerosis.

[15]  J. Honnorat,et al.  Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. , 2010, Brain : a journal of neurology.

[16]  X. Montalban,et al.  Orchestrating innate immune responses in multiple sclerosis: Molecular players , 2010, Journal of Neuroimmunology.

[17]  R. Liblau,et al.  Transgenic mouse models of multiple sclerosis , 2010, Cellular and Molecular Life Sciences.

[18]  Satoshi O. Suzuki,et al.  Aquaporin-4 astrocytopathy in Baló’s disease , 2010, Acta Neuropathologica.

[19]  R. Pope,et al.  Toll‐like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis , 2010, Journal of leukocyte biology.

[20]  K. Fujihara,et al.  Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination , 2010, Acta Neuropathologica.

[21]  J. Sloane,et al.  Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2 , 2010, Proceedings of the National Academy of Sciences.

[22]  G. Pirianov,et al.  Attenuation of proliferation in oligodendrocyte precursor cells by activated microglia , 2010, Journal of neuroscience research.

[23]  S. Pawate,et al.  The role of infections in the pathogenesis and course of multiple sclerosis , 2010, Annals of Indian Academy of Neurology.

[24]  Andrew E. Parker,et al.  Targeting Toll-like receptors: emerging therapeutics? , 2010, Nature Reviews Drug Discovery.

[25]  S. Sriram,et al.  LPS mediated injury to oligodendrocytes is mediated by the activation of nNOS: relevance to human demyelinating disease. , 2010, Nitric oxide : biology and chemistry.

[26]  M. Lamkanfi,et al.  NOD‐like receptor (NLR) signaling beyond the inflammasome , 2010, European journal of immunology.

[27]  M. Papadopoulos,et al.  Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. , 2010, Brain : a journal of neurology.

[28]  J. Honnorat.  Autoimmune limbic encephalitis: an expanding concept , 2010, The Lancet Neurology.

[29]  L. Kasper,et al.  Multiple sclerosis immunology , 2010, Neurology.

[30]  J. Parratt,et al.  Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions , 2009, Annals of neurology.

[31]  L. Steinman,et al.  Innate and Adaptive Autoimmunity Directed to the Central Nervous System , 2009, Neuron.

[32]  A. Parker,et al.  Toll-like receptors and NOD-like receptors in rheumatic diseases , 2009, Arthritis research & therapy.

[33]  C. Lucchinetti,et al.  Humoral pattern II multiple sclerosis pathology not associated with neuromyelitis Optica IgG. , 2009, Archives of neurology.

[34]  B. Weinshenker,et al.  Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. , 2009, Archives of neurology.

[35]  S. Lehnardt,et al.  Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injury , 2009, Glia.

[36]  B. Weinshenker,et al.  Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. , 2009, Archives of neurology.

[37]  C. Vedeler,et al.  Autoimmune limbic encephalitis , 2009, Acta neurologica Scandinavica. Supplementum.

[38]  L. Bø,et al.  The histopathology of grey matter demyelination in multiple sclerosis , 2009, Acta neurologica Scandinavica. Supplementum.

[39]  C. Bryant,et al.  Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer , 2009, Pharmacological Reviews.

[40]  S. Rivest.  Regulation of innate immune responses in the brain , 2009, Nature Reviews Immunology.

[41]  C. Good,et al.  HISTOPATHOLOGY OF VGKC ANTIBODY–ASSOCIATED LIMBIC ENCEPHALITIS , 2009, Neurology.

[42]  N. Sibson,et al.  Systemic Inflammatory Response Reactivates Immune-Mediated Lesions in Rat Brain , 2009, The Journal of Neuroscience.

[43]  V. O’Donnell,et al.  Peroxynitrite-mediated lipid oxidation and nitration: mechanisms and consequences. , 2009, Archives of biochemistry and biophysics.

[44]  H. Weiner,et al.  The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease? , 2009, Annals of neurology.

[45]  L. O’Neill,et al.  The interleukin‐1 receptor/Toll‐like receptor superfamily: 10 years of progress , 2008, Immunological reviews.

[46]  C. Lucchinetti,et al.  Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2 , 2008, The Journal of experimental medicine.

[47]  A. Kraft,et al.  Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment , 2008, Expert opinion on drug metabolism & toxicology.

[48]  L. O’Neill,et al.  Signalling adaptors used by Toll-like receptors: an update. , 2008, Cytokine.

[49]  B. Trapp,et al.  Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.

[50]  P. Pickkers,et al.  The effect of systemic iNOS inhibition during human endotoxemia on the development of tolerance to different TLR-stimuli , 2008, Innate immunity.

[51]  L. O’Neill.  Primer: Toll-like receptor signaling pathways—what do rheumatologists need to know? , 2008, Nature Clinical Practice Rheumatology.

[52]  H. Weiner.  A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis , 2008, Journal of Neurology.

[53]  S. Scherer,et al.  Two Distinct Heterotypic Channels Mediate Gap Junction Coupling between Astrocyte and Oligodendrocyte Connexins , 2007, The Journal of Neuroscience.

[54]  R. Reynolds,et al.  Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. , 2007, Brain : a journal of neurology.

[55]  R. Reynolds,et al.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.

[56]  H. Lassmann,et al.  Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? , 2007, Brain : a journal of neurology.

[57]  Roland Martin,et al.  Multiple sclerosis: a complicated picture of autoimmunity , 2007, Nature Immunology.

[58]  B. Weinshenker,et al.  The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.

[59]  W. Brück,et al.  Contrasting potential of nitric oxide and peroxynitrite to mediate oligodendrocyte injury in multiple sclerosis , 2007, Glia.

[60]  H. Atkins,et al.  Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. , 2007, Brain : a journal of neurology.

[61]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.

[62]  R. Ravid,et al.  Identification of soluble CD14 as an endogenous agonist for Toll‐like receptor 2 on human astrocytes by genome‐scale functional screening of glial cell derived proteins , 2007, Glia.

[63]  M. Schneemann,et al.  Macrophage biology and immunology: man is not a mouse , 2007, Journal of leukocyte biology.

[64]  J. Correale,et al.  Association between parasite infection and immune responses in multiple sclerosis , 2007, Annals of neurology.

[65]  B. Weinshenker,et al.  NMO-IgG: A Specific Biomarker for Neuromyelitis Optica , 2006, Disease markers.

[66]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[67]  J. Benjamins,et al.  Nitric oxide synthase expression and nitric oxide toxicity in oligodendrocytes. , 2006, Antioxidants & redox signaling.

[68]  M. Rovaris,et al.  Secondary progressive multiple sclerosis: current knowledge and future challenges , 2006, The Lancet Neurology.

[69]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.

[70]  E. Abraham,et al.  High mobility group box 1 protein interacts with multiple Toll-like receptors. , 2006, American journal of physiology. Cell physiology.

[71]  Subramaniam Sriram,et al.  Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis , 2005, Annals of neurology.

[72]  W. Brück.  Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis , 2005, Journal of Neurology.

[73]  J. Antel,et al.  TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes1 , 2005, The Journal of Immunology.

[74]  A. Bar-Or,et al.  Microglia and multiple sclerosis , 2005, Journal of neuroscience research.

[75]  J. Volpe,et al.  Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[76]  D. Ron,et al.  Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-γ , 2005, The Journal of cell biology.

[77]  Kenneth J. Smith,et al.  Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide , 2005, Brain : a journal of neurology.

[78]  Roland Martin,et al.  Immunology of multiple sclerosis. , 2005, Annual review of immunology.

[79]  Sumana Chakravarty,et al.  Toll-Like Receptor 4 on Nonhematopoietic Cells Sustains CNS Inflammation during Endotoxemia, Independent of Systemic Cytokines , 2005, The Journal of Neuroscience.

[80]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[81]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[82]  F. Barkhof,et al.  CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis , 2004, Neurology.

[83]  K. Arimura,et al.  Juvenile form of Alexander disease with GFAP mutation and mitochondrial abnormality , 2004, Neurology.

[84]  R. Hohlfeld,et al.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[85]  T. Giese,et al.  Expression and function of Toll-like receptor 3 in human astrocytes , 2004 .

[86]  Anne B. Johnson.  Alexander Disease: A Leukodystrophy Caused by a Mutation in GFAP , 2004, Neurochemical Research.

[87]  G. Giovannoni,et al.  Cerebrospinal fluid nitrite/nitrate correlated with oxyhemoglobin and outcome in patients with subarachnoid hemorrhage , 2004, Journal of the Neurological Sciences.

[88]  M. Barnett,et al.  Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.

[89]  R. Ransohoff,et al.  The CD4–Th1 model for multiple sclerosis: a crucial re-appraisal , 2004 .

[90]  J. Rash,et al.  Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: Implications from normal and connexin32 knockout mice , 2003, Glia.

[91]  Shizuo Akira,et al.  Toll-like Receptor Signaling* , 2003, Journal of Biological Chemistry.

[92]  E. Frohman.  Multiple sclerosis. , 2003, The Medical clinics of North America.

[93]  Guy C. Brown,et al.  Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria , 2003, Molecular Neurobiology.

[94]  J. Rash,et al.  Astrocyte and Oligodendrocyte Connexins of the Glial Syncytium in Relation to Astrocyte Anatomical Domains and Spatial Buffering , 2003, Cell communication & adhesion.

[95]  C. Du,et al.  Chlamydia pneumoniae Infection of the Central Nervous System Worsens Experimental Allergic Encephalitis , 2002, The Journal of experimental medicine.

[96]  R. Ravid,et al.  Broad Expression of Toll‐Like Receptors in the Human Central Nervous System , 2002, Journal of neuropathology and experimental neurology.

[97]  W. Hop,et al.  Prospective study on the relationship between infections and multiple sclerosis exacerbations. , 2002, Brain : a journal of neurology.

[98]  Pamela L. Follett,et al.  The Toll-Like Receptor TLR4 Is Necessary for Lipopolysaccharide-Induced Oligodendrocyte Injury in the CNS , 2002, The Journal of Neuroscience.

[99]  T. Ahrens,et al.  Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4 , 2002, The Journal of experimental medicine.

[100]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[101]  W. Hancock,et al.  Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 41 , 2001, The Journal of Immunology.

[102]  C. Guaza,et al.  LPS/IFN‐γ cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti‐inflammatory cytokine IL‐10 , 2001, The European journal of neuroscience.

[103]  K. Smith,et al.  Tumour necrosis factor-α has few morphological effects within the dorsal columns of the spinal cord, in contrast to its effects in the peripheral nervous system , 2000, Journal of Neuroimmunology.

[104]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[105]  V. Perry,et al.  In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines. , 1999, Journal of neuropathology and experimental neurology.

[106]  V. Perry,et al.  Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord , 1999, The European journal of neuroscience.

[107]  V. Perry,et al.  Cytokine-induced acute inflammation in the brain and spinal cord. , 1999, Journal of neuropathology and experimental neurology.

[108]  N. Bhat,et al.  Cytokine Induction of Inducible Nitric Oxide Synthase in an Oligodendrocyte Cell Line , 1999, Journal of neurochemistry.

[109]  S. Rivest,et al.  The Bacterial Endotoxin Lipopolysaccharide has the Ability to Target the Brain in Upregulating Its Membrane CD14 Receptor Within Specific Cellular Populations , 1998, Brain pathology.

[110]  R. Dermietzel,et al.  Gap junctions in health and disease , 1998, Virchows Archiv.

[111]  M. V. von Herrath,et al.  Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[112]  C. Lowenstein,et al.  Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes , 1997, Journal of neuroscience research.

[113]  S. Izumo,et al.  Neuropathology of HTLV-1-associated myelopathy (HAM/TSP). , 1997, Leukemia.

[114]  Moses Rodriguez,et al.  Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor‐α in the central nervous system , 1997, European journal of immunology.

[115]  M. Rodriguez,et al.  Indictment of the microglia as the villain in multiple sclerosis , 1997, Neurology.

[116]  G. Kollias,et al.  Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. , 1997, Journal of immunology.

[117]  B. Trapp,et al.  Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. , 1996, The Journal of clinical investigation.

[118]  B. Popko,et al.  Targeted CNS Expression of Interferon-γ in Transgenic Mice Leads to Hypomyelination, Reactive Gliosis, and Abnormal Cerebellar Development , 1996, Molecular and Cellular Neuroscience.

[119]  J. Baskerville,et al.  Long-term and short-term outcome of multiple sclerosis: a 3-year follow-up study. , 1996, Archives of neurology.

[120]  L. Gold,et al.  Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. , 1996, The Journal of clinical investigation.

[121]  G. Kollias,et al.  Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[122]  J. Gilroy,et al.  ROLE OF BACTERIAL INFECTION IN EXACERBATION OF MULTIPLE SCLEROSIS , 1995, American journal of physical medicine & rehabilitation.

[123]  V. Perry,et al.  Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette-Guérin , 1995, Neuroscience.

[124]  M. Denis.  Human monocytes/macrophages: NO or no NO? , 1994, Journal of leukocyte biology.

[125]  L. Mucke,et al.  Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[126]  J. Kurtzke.  Epidemiologic evidence for multiple sclerosis as an infection , 1993, Clinical Microbiology Reviews.

[127]  T. Bergström,et al.  Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study , 1993, Journal of Neurology.

[128]  V. Perry,et al.  The inflammatory response in the CNS , 1992, Neuropathology and applied neurobiology.

[129]  V. Perry,et al.  Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system , 1992, The Journal of experimental medicine.

[130]  R. Dermietzel,et al.  Gap junctions between cultured astrocytes: immunocytochemical, molecular, and electrophysiological analysis , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[131]  Shimon Sakaguchi,et al.  Regulatory T cells exert checks and balances on self tolerance and autoimmunity , 2010, Nature Immunology.

[132]  S. Izumo.  The 50th Anniversary of Japanese Society of Neuropathology Memorial Symposium: Milestones in Neuropathology from Japan Neuropathology of HTLV-1-associated myelopathy (HAM/TSP) , 2010 .

[133]  J. V. van Noort,et al.  Toll-like receptors in the CNS: implications for neurodegeneration and repair. , 2009, Progress in brain research.

[134]  T. Owens.  Toll-like receptors in neurodegeneration. , 2009, Current topics in microbiology and immunology.

[135]  M. Graeber,et al.  Microglia: biology and pathology , 2009, Acta Neuropathologica.

[136]  Christopher B Wilson,et al.  Regulation of interferon-gamma during innate and adaptive immune responses. , 2007, Advances in immunology.

[137]  B. Weinshenker,et al.  The Natural History of Multiple Sclerosis: Update 1998 , 1998, Seminars in neurology.

[138]  N. Blau,et al.  Nitrite generation in interleukin-4-treated human macrophage cultures does not involve the nitric oxide synthase pathway. , 1997, The Journal of infectious diseases.

[139]  B. Weinshenker,et al.  Natural history of multiple sclerosis , 1994, Annals of neurology.

[140]  C. Colton,et al.  Microglia, an in vivo source of reactive oxygen species in the brain. , 1993, Advances in neurology.